ZA725519B - Medicines containing 2-pyridones - Google Patents
Medicines containing 2-pyridonesInfo
- Publication number
- ZA725519B ZA725519B ZA725519A ZA725519A ZA725519B ZA 725519 B ZA725519 B ZA 725519B ZA 725519 A ZA725519 A ZA 725519A ZA 725519 A ZA725519 A ZA 725519A ZA 725519 B ZA725519 B ZA 725519B
- Authority
- ZA
- South Africa
- Prior art keywords
- pyridones
- medicines containing
- medicines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2140712A DE2140712A1 (de) | 1971-08-13 | 1971-08-13 | 2-pyridone enthaltende arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA725519B true ZA725519B (en) | 1973-04-25 |
Family
ID=5816721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA725519A ZA725519B (en) | 1971-08-13 | 1972-08-11 | Medicines containing 2-pyridones |
Country Status (6)
Country | Link |
---|---|
BE (1) | BE787523A (fr) |
DE (1) | DE2140712A1 (fr) |
FR (1) | FR2150750B1 (fr) |
GB (1) | GB1388001A (fr) |
NL (1) | NL7210798A (fr) |
ZA (1) | ZA725519B (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006244072B2 (en) * | 2005-05-10 | 2012-09-20 | Intermune, Inc. | Pyridone derivatives for modulating stress-activated protein kinase system |
US8304413B2 (en) | 2008-06-03 | 2012-11-06 | Intermune, Inc. | Compounds and methods for treating inflammatory and fibrotic disorders |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
EP3126362B1 (fr) | 2014-04-02 | 2022-01-12 | Intermune, Inc. | Pyridinones anti-fibrotiques |
-
0
- BE BE787523D patent/BE787523A/fr unknown
-
1971
- 1971-08-13 DE DE2140712A patent/DE2140712A1/de active Pending
-
1972
- 1972-08-07 NL NL7210798A patent/NL7210798A/xx not_active Application Discontinuation
- 1972-08-09 FR FR7228676A patent/FR2150750B1/fr not_active Expired
- 1972-08-11 GB GB3765072A patent/GB1388001A/en not_active Expired
- 1972-08-11 ZA ZA725519A patent/ZA725519B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FR2150750A1 (fr) | 1973-04-13 |
BE787523A (fr) | 1973-02-12 |
DE2140712A1 (de) | 1973-02-15 |
GB1388001A (en) | 1975-03-19 |
NL7210798A (fr) | 1973-02-15 |
FR2150750B1 (fr) | 1976-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA722506B (en) | Tetrachlorophthalide compounds | |
IL39181A0 (en) | Insulin product | |
IE35991L (en) | Camphor-containing pharmaceutical composition | |
AU4916772A (en) | Benzimidazolyl-2-aminoimidazolines | |
IE35910B1 (en) | Pharmaceutical composition | |
ZA725519B (en) | Medicines containing 2-pyridones | |
AU4209872A (en) | Container-agitator | |
GB1369721A (en) | Organotin compounds | |
AU4775472A (en) | New polyepoxide-polysiloxane compounds | |
AU4604872A (en) | Medicines with ulcer-healing effect | |
IL38792A0 (en) | New aminoisoquinolines | |
ZA721363B (en) | Pharmaceutical composition | |
JPS5123342A (en) | Kazariito no seizoho | |
ZA721612B (en) | Cyclic compounds | |
JPS51110123A (en) | gasorinkikan no judokugasuboshihoho | |
CA34756S (en) | Tablet | |
CA34279S (en) | Tablet | |
CA34749S (en) | Tablet | |
CA34758S (en) | Tablet | |
CA34746S (en) | Tablet | |
CA34757S (en) | Tablet | |
CA34243S (en) | Bottle | |
CA33771S (en) | Bottle | |
CA34346S (en) | Bottle | |
CA34347S (en) | Bottle |